Matt Drever

Matt Drever is currently serving as the Vice President of Molecular Biology and Protein Engineering at ArsenalBio. Prior to this, Matt held positions such as Senior Director at Kite Pharma, Director at Cell Design Labs (acquired by Kite Pharma), and Associate Director at Tizona Therapeutics, Inc. Matt's experience also includes roles at Theravance Biopharma, Inc., Pfizer, and Haptogen Ltd. Matt obtained a PhD in Molecular Biology from the University of Aberdeen.